Phathom Pharmaceuticals, Inc. (PHAT) Tops Q3 EPS by 13c

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q3 EPS of ($0.76), $0.13 better than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c